Advertisement


Related Videos

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Opening Session Panel Discussion

Opportunities to Optimize Cancer Policies Panel Discussion

Advertisement

Advertisement




Advertisement